Survey of urologists on clients' demand for screening for prostate cancer in Nigeria

Nigerian Journal of Clinical Practice

Volumn 14, Issue 2, 2011, Pages 151-153

  Ajape, A A ^a,b   Mustapha, K ^a,b   Lawal, I O ^a,b   Mbibu, H N ^a,b  

^a UNIVERSITY OF ILORIN   (Nigeria)

^b AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

Cancer; Demand; Prostate; Prostate cancer; Screening; Urologist survey

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; DIGITAL RECTAL EXAMINATION; ECHOGRAPHY; HEALTH CARE SURVEY; HEALTH SERVICE; HUMAN; INCIDENTAL FINDING; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; NIGERIA; PHYSICIAN; PROSTATE TUMOR; QUESTIONNAIRE; UROLOGY;

ADULT; BIOPSY, FINE-NEEDLE; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; DIGITAL RECTAL EXAMINATION; HEALTH CARE SURVEYS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INCIDENTAL FINDINGS; MALE; MASS SCREENING; MIDDLE AGED; NIGERIA; PHYSICIANS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; TUMOR MARKERS, BIOLOGICAL; UROLOGY;

EID: 80052487372     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.84004     Document Type: Article

References (13)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Osegbe DN. Prostate Cancer in Nigerians: Facts and Non-facts. J Urol 1997;157:1340-3 (Pubitemid 27130810)
3. Nwofor AME, Oranusi CK. Cancer of the Prostate: Experience at Nnewi, Southeast, Nigeria. Nig J Clin Pract 2004;7:65-68.
4. Ogunbiyi JO, Shittu OB. Increased Incidence of Prostate Cancer in Nigerians. J Nat Med Assoc 1999;91:159-64.
5. Eke N, Sapira MK. Prostate Cancer in Port Harcourt, Nigeria: Features and Outcome. Nig J Surg Res 2002;4:34-44.
6. Dawan D, Rafindadi AH, Kalayi GD. Benign Prostatic Hyperplasia and Prostate Carcinoma in Native Africans. BJU Int 2000;85:1074-77. (Pubitemid 30348802)
7. Bensalah K, Lotan Y, Karam JA, Shariat SF. New circulating biomarkers for prostate cancer. Prost Cancer Prost Dis 2008;11:112-20. (Pubitemid 351676597)
8. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990;143:1146?52.
9. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995;25:289?94.
10. Ulmert D, Cronin AM, Bjork T, O'Brien MF, Scardino PT, Eastham JA, et al. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study. BMC Med 2008;6:6-13.
11. Makarov DV, Carter HB. The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate. J Urol 2006;176:2383-5. (Pubitemid 44665981)
12. Romero FR, Romero KR, Brenny FT, Pilati R, Kulysz D, de Oliveira Junior FC. Reasons why patients reject digital rectal examination when screening for prostate cancer. Arch Esp Urol 2008;61:759-65.
13. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-61.